EMAIL THIS PAGE TO A FRIEND

Die Pharmazie

Metabolism of dynorphin A(1-13).


PMID 15212298

Abstract

Dynorphin A(1-13), a tridecapeptide of the endogenous opioid peptides, has modest effects in reducing mild opiate withdrawal in humans. Previous studies revealed that dynorphin also potentiates the analgesic effect of morphine in morphine-tolerant rats and mice. The therapeutic potential of dynorphin A(1-13) is limited due to extensive metabolism by human metabolic enzymes resulting in an in vivo half-life of less than one minute. Chemical modifications of dynorphin A(1-13), such as N-methylation of Tyr1 and amidation of the C-terminus have been shown to be effective in protecting against the proteolytic enzymes in human plasma. This article is a general review of the metabolism of dynorphin A(1-13) in human plasma and CSF.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D7017
Dynorphin A Porcine Fragment 1-13, ≥97% (HPLC)
C75H126N24O15